跳至主要内容
临床试验/NCT03146676
NCT03146676招募中不适用

The Ohio State University Dermatology Biorepository

Ohio State University1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2017年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
175
试验地点
1
主要终点
Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders

研究概览

简要总结

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

详细描述

A variety of molecular techniques can be used to investigate diseases by analyzing protein, DNA, and RNA. Flow cytometry, Polymerase chain reaction (PCR), histology and immunohistochemistry are assays which can identify specific cell populations and provide valuable information regarding the pathologic characteristics of those populations. Flow cytometry analyzes the surface markers of cells. Histology and immunohistochemistry further characterize surface and cellular molecules and aid in the diagnosis of certain skin diseases. Gene expression profiling allows investigators to examine the genes detectable to determine the function of the cells involved, and PCR techniques are useful for the diagnosis of certain conditions and for DNA analysis.

By procuring blood, skin tissue, and swab samples from patients with and without neoplastic and inflammatory skin disorders at the time of their appointments, the hypothesize that future translational research can be conducted on such specimens using the aforementioned techniques to further understand disease mechanisms in cutaneous disorders, and to potentially discover defective function and genetic mutations within cells from patients with neoplastic and inflammatory skin disorders. By establishing a tissue bank, we aim to lay the foundation for future work that will improve our understanding of the biology and natural history of neoplastic and inflammatory cutaneous diseases.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
  • Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
  • Willingness to participate in a research study.

排除标准

  • Inability to provide informed consent

结局指标

主要结局

Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ben H Kaffenberger

Dermatologist

Ohio State University

研究点 (1)

Loading locations...

相似试验

The Ohio State University Dermatology Biorepository | 临床试验